Levin Capital Strategies’s Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 CNDA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-60,000
Closed -$12K 288
2022
Q2
$12K Hold
60,000
﹤0.01% 263
2022
Q1
$31K Buy
+60,000
New +$39.7K ﹤0.01% 307

Other funds holding CNDA.WS

Levin Capital Strategies's CNDA.WS Position: Q3 2022 in Review

Levin Capital Strategies sold out of Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (CNDA.WS) in Q3 2022, closing a stake of 60,000 shares — an estimated $12K sold.

Levin Capital Strategies first reported a position in CNDA.WS in Q1 2022 and held it in 2 quarters. The position peaked at $31K in Q1 2022. 23 funds tracked by Wall St. Rank hold CNDA.WS as of Q3 2022.

  • Levin Capital Strategies reported no remaining Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • Levin Capital Strategies sold 60,000 Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q3 2022, an estimated $12K.
  • Levin Capital Strategies first reported a position in Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q1 2022 and held it in 2 quarters.
  • Levin Capital Strategies's Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $31K in Q1 2022.
  • 23 funds tracked by Wall St. Rank held Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q3 2022.

Based on Levin Capital Strategies's 13F filing for Q3 2022, filed 8 Nov 2022.